scholarly journals Long-Term Trends in the Survival of Women with Endometrial Cancer in Canada: A Population-Based Study

2012 ◽  
Vol 03 (05) ◽  
pp. 853-858
Author(s):  
Laurie Elit ◽  
Alice Lytwyn ◽  
Noori Akhtar-Danesh
Pancreatology ◽  
2016 ◽  
Vol 16 (2) ◽  
pp. 259-265 ◽  
Author(s):  
Gileh-Gol Akhtar-Danesh ◽  
Christian Finley ◽  
Noori Akhtar-Danesh

2005 ◽  
Vol 80 (6) ◽  
pp. 753-758 ◽  
Author(s):  
James P. Burke ◽  
Ian D. Hay ◽  
Fiona Dignan ◽  
John R. Goellner ◽  
Sara J. Achenbach ◽  
...  

2005 ◽  
Vol 80 (6) ◽  
pp. 753-758 ◽  
Author(s):  
James P. Burke ◽  
Ian D. Hay ◽  
Fiona Dignan ◽  
John R. Goellner ◽  
Sara J. Achenbach ◽  
...  

2018 ◽  
Vol 7 (5) ◽  
pp. 768-776 ◽  
Author(s):  
Nadine M Vaninetti ◽  
David B Clarke ◽  
Deborah A Zwicker ◽  
Churn-Ern Yip ◽  
Barna Tugwell ◽  
...  

Purpose Sellar masses may present either with clinical manifestations of mass effect/hormonal dysfunction (CMSM) or incidentally on imaging (pituitary incidentaloma (PI)). This novel population-based study compares these two entities. Methods Retrospective analysis of all patients within a provincial pituitary registry between January 2006 and June 2014. Results Nine hundred and three patients were included (681 CMSM, 222 PI). CMSM mainly presented with secondary hormone deficiencies (SHDs) or stalk compression (29.7%), whereas PIs were found in association with neurological complaints (34.2%) (P < 0.0001). PIs were more likely to be macroadenomas (70.7 vs 49.9%; P < 0.0001). The commonest pathologies among CMSM were prolactinomas (39.8%) and non-functioning adenomas (NFAs) (50%) in PI (P < 0.0001). SHDs were present in 41.3% CMSM and 31.1% PI patients (P < 0.0001) and visual field deficit in 24.2 and 29.3%, respectively (P = 0.16). CMSM were more likely to require surgery (62.9%) than PI (35.8%) (P < 0.0005). The commonest surgical indications were impaired vision and radiological evidence of optic nerve compression. Over a follow-up period of 5.7 years for CMSM and 5.0 years for PI, tumour growth/recurrence occurred in 7.8% of surgically treated CMSM and 2.6% without surgery and PI, 0 and 4.9%, respectively (P = 1.0). There were no significant differences in the risk of new-onset SHD in CMSM vs PI in those who underwent surgery (P = 0.7) and those who were followed without surgery (P = 0.58). Conclusions This novel study compares the long-term trends of PI with CMSM, highlighting the need for comprehensive baseline and long-term radiological and hormonal evaluations in both entities.


BMJ ◽  
2015 ◽  
pp. h5949 ◽  
Author(s):  
Babak Khoshnood ◽  
Maria Loane ◽  
Hermien de Walle ◽  
Larraitz Arriola ◽  
Marie-Claude Addor ◽  
...  

BMC Cancer ◽  
2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Keiu Paapsi ◽  
Aleksei Baburin ◽  
Sirje Mikkel ◽  
Margit Mägi ◽  
Kadri Saks ◽  
...  

Abstract Background Childhood cancers represent a small proportion of all cancers but are still a major public health problem. The study analysed long-term trends in childhood cancer incidence and survival in Estonia in relation to societal and health care transition. Methods Data on all malignant tumours, diagnosed in children aged 0–14 during 1970–2016, were derived from the Estonian Cancer Registry. Age-standardised (World standard) incidence rates were calculated by ICCC-3 site groups and joinpoint regression was used to estimate annual percentage change (APC) for incidence trends. Cohort and period approach were used to estimate 5-year survival. Internal age standardisation was applied. Results A total of 1628 incident cancer cases were diagnosed during the study period and overall incidence increased significantly at a rate of 0.5% per year. Significant increases were seen for neuroblastoma and germ cell tumours, for lymphoid leukemias and some CNS sub-sites. At the same time, decline in incidence was seen in almost all subgroups of unspecified neoplasms. The overall 5-year survival improved from 24% in 1970–1979 to 73% in 2010–2016, with the largest changes occurring in the 1990s and 2000s. For many sites, survival increase thereafter has been marginal. Conclusion In this first comprehensive population-based study of childhood cancer incidence and survival in Estonia, long-term trends are shown in the context of societal and health care changes. Even though the increasing incidence of some sites may, at least partially, be explained by improved diagnostics reflected in the decreased incidence of unspecified neoplasms, the overall cancer incidence in children seems to be rising. Rapid progress in diagnosis and care have improved childhood cancer survival immensely, but deficit in Estonia persists compared to other European countries. Results of the study accentuate the need for a more in-depth analysis of clinical data, but also for the prioritization of childhood cancer in Estonia, to ensure access to standard care and innovative treatments.


2020 ◽  
Vol 9 (19) ◽  
pp. 7330-7340
Author(s):  
Jo Aoe ◽  
Yuri Ito ◽  
Keisuke Fukui ◽  
Masashi Nakayama ◽  
Toshitaka Morishima ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document